Leonteq Securities’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.4K Buy
2,288
+1,996
+684% +$47.9K ﹤0.01% 844
2026
Q2
$9.8K Sell
292
-1,503
-84% -$37.3K ﹤0.01% 1028
2026
Q1
$37.6K Buy
1,795
+1,333
+289% +$30K ﹤0.01% 900
2025
Q4
$10.6K Sell
462
-25
-5% -$822 ﹤0.01% 1188
2025
Q3
$14.6K Sell
487
-11,513
-96% -$345K ﹤0.01% 1077
2025
Q2
$436K Buy
+12,000
New +$433K 0.02% 415
2025
Q1
– Sell
-1,510
Closed -$63.5K – 1325
2024
Q4
$63.5K Buy
+1,510
New +$74.9K ﹤0.01% 784
2024
Q2
– Sell
-124
Closed -$5.79K – 1279
2024
Q1
$5.79K Sell
124
-393
-76% -$18.5K ﹤0.01% 1064
2023
Q4
$24.7K Sell
517
-1,057
-67% -$41K ﹤0.01% 912
2023
Q3
$56.1K Buy
1,574
+574
+57% +$22.7K ﹤0.01% 782
2023
Q2
$46.1K Sell
1,000
-300
-23% -$13.9K ﹤0.01% 841
2023
Q1
$52.1K Hold
1,300
– – ﹤0.01% 792
2022
Q4
$60.2K Hold
1,300
– – ﹤0.01% 784
2022
Q3
$53.8K Hold
1,300
– – ﹤0.01% 792
2022
Q2
$77.6K Hold
1,300
– – ﹤0.01% 734
2022
Q1
$94.4K Buy
1,300
+1,000
+333% +$69.6K ﹤0.01% 746
2021
Q4
$25.2K Buy
+300
New +$24.4K ﹤0.01% 1009
2021
Q2
– Sell
-2,244
Closed -$256K – 1118
2021
Q1
$256K Sell
2,244
-257
-10% -$35K 0.02% 515
2020
Q4
$346K Buy
+2,501
New +$297K 0.02% 475

Other funds holding RARE

Leonteq Securities's RARE Position: Q3 2026 in Review

Leonteq Securities increased its Ultragenyx Pharmaceutical (RARE) stake by 684% in Q3 2026, buying an estimated $47.9K and bringing the position to 2,288 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Leonteq Securities first reported a position in RARE in Q4 2020 and has held it in 19 quarters since. The position peaked at $436K in Q2 2025. 186 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • Leonteq Securities held 2,288 shares of Ultragenyx Pharmaceutical worth $34.4K as of Q3 2026.
  • Leonteq Securities bought 1,996 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $47.9K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #844 holding.
  • Leonteq Securities first reported a position in Ultragenyx Pharmaceutical in Q4 2020 and has held it in 19 quarters since.
  • Leonteq Securities's Ultragenyx Pharmaceutical position peaked at $436K in Q2 2025.
  • 186 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.